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It is now  well  known  that  sensitized  lymphocytes release various  effector 
substances when stimulated by specific antigen in vitro (1). These substances 
have been collectively defined as "lymphokines." The elaboration of some, if 
not all of these, is correlated with the state of delayed hypersensitivity of the 
lymphocytes donor  (1-2).  Although  a  variety of observations have provided 
indirect  evidence  that  the  various  manifestations  of  cellular  immunity  are 
mediated by the T  cell subpopulation of lymphocytes, there are only very few 
observations  which  show  directly  that  any  of  the  various  lymphokines  are 
produced by T  cells (3). This has been mainly because of the lack of a suitable 
marker for T cells in guinea pigs, in which species most of the studies on delayed 
hypersensitivity have been performed. 
Recently it has been shown that lymphocytes of various species including the 
guinea pig may be divided into two populations on the basis of whether or not 
they possess receptors for the third  component of complement on their surface 
(4).  These populations,  known  as  complement receptor lymphocytes (CRL) 1 
and  noncomplement  receptor  lymphocytes  (NCRL),  have  been  shown  to 
correspond respectively to B cells and T  cells (5, 6). 
Previously, we have reported  that  the macrophage disappearance reaction 
(MDR)  is mediated  by NCRL  through  the  release  of  a  soluble factor from 
such cells which affects the behavior of macrophages in peritoneal exudates in 
the  intact  animal  (3).  CRL had  no  detectable  activity in  this  regard.  These 
observations  therefore provided  evidence  for  the  production  of  at  least  one 
lymphokine by a  subpopulation of lymphocytes corresponding to T  cells. 
The present series of experiments were designed to study the ability of puri- 
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dinitrophenylated  bovine serum albumin; DNP-EA,  dinitrophenylated egg albumin;  EA, 
egg albumin; EAC, erythrocytes; MDR, macrophage disappearance reaction; MIF, migra- 
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fled  CRL  and NCRL  to produce  migration  inhibition factor  (MIF),  the first 
described  and best known  of  the various  lymphokines. 
Materials and Methods 
Immunization.--Female  Hartley guinea pigs weighing 350-400  g  were immuinized with 
footpad injections of 100/zg of egg albumin (EA), dinitrophenylated egg albumin (DNP-EA), 
or dinitrophenylated bovine serum albumin (DNP-BSA) in complete Freund adjuvant (Difco 
Laboratories, Detroit, Mich.), or the adjuvant alone. In a preliminary experiment, a group of 
40 nonimmune animals were skin tested with 20/zg of tuberculin purified protein derivative 
(PPD)  (Parke, Davis, and Co. Detroit, Mich.) to demonstrate that those guinea pigs were not 
sensitive to this antigen. All these animals were negative to skin test. This was done in an 
attempt to exclude the possibility of pre-existing sensitization to PPD in our animal popula- 
tion. However, all the guinea pigs which served as normal controls, as a source of "nonimmune" 
lymphocytes, in the present experiments were not pretested, since such treatment is known to 
either sensitize or to enhance a pre-existing subthreshold sensitivity (7). However, they were 
obtained in the same shipment and from the same supplier as those found to be PPD negative. 
Lymphocyte Suspensions.--Sensitized  lymphocytes were obtained from lymph nodes drain- 
ing the sites of antigen injection in guinea pigs, and were removed 8 or 9 days after immuniza- 
tion. Normal lymphocytes were obtained from  axillary, popliteal, inguinal, and iliac lymph 
nodes,  or  from  spleens of  normal guinea pigs.  Cell suspensions were made in RPMI  1640 
medium  (Associated  Biomedic Systems, Inc.,  Buffalo,  N.Y.),  supplemented with penicillin 
(50 U/ml) and streptomycin (50 #g/ml). 
Preparation of Indicator Erythrocytes.--Sheep  erythrocytes were sensitized with antibody 
and guinea pig complement as described previously (3). Briefly, equal volume of a 5% suspen- 
sion of erythrocytes and a  1:200 dilution of rabbit antisheep hemolysin (amboceptor, Hyland 
Labc:~.tories, Los Angeles, Calif.) in Veronal-buffered saline (VBS), pH 7.4, were incubated at 
37°C  for 30 rain. The sensitized cells were washed twice and resuspended to the original con- 
centration. An equal volume of a  1:100 dilution of fresh guinea pig serum (as a complement 
source) in VBS was added and incubated at 37°C for 20 min. After three washings in VBS and 
two washings in phosphate-buffered saline (PBS), pH 7.4,  containing 0.01  M  EDTA, a  final 
suspension of sensitized erythrocytes (EAC) were adjusted to 1 X  109/ml. These cells, which 
do not lyse spontaneously, were used for the identification and separation of CRL. 
Separation of CRL and NCRL.--The  cell suspensions prepared as described above were 
resnspended in EDTA-PBS.  Equal volumes of EAC (1  X  109/ml) and cell suspension (5  X 
107/ml) were mixed and incubated at 37°C for 15 rain to produce erythrocyte rosettes around 
the CRL present in the suspension. Then an equal volume of a  1:50 dilution of amboceptor 
was added, and the mixture incubated for another 20 min. This caused agglutination of the 
rosette-bearing lymphocytes. The preparation was then centrifuged at  1,500  rpm for 4  min 
and resuspended in the same buffer. The suspension was incubated at 37°C for 30--40 min to 
allow clumping and settling to occur. The suspension was left standing at 4°C for 20 min and 
the rosette-free supernatant which contained NCRL  were removed. Then more buffer was 
added to resuspend the rosette-containing cells.  These procedures were repeated four to five 
times to obtain the final CRL-rich cell suspension. The removal of the rosette erythrocytes on 
the CRL was achieved by treatment with C3 inactivator as described previously (3). In some 
experiments this was accomplished by treatment with 0.5% NH4C1 solution as reported else- 
where (8). These procedures resulted in a final population of lymphocytes containing 85-90% 
of CRL. The recovery ratio of CRL was 20-30%. NCRL had a  purity of greater than 95% 
and their recovery ratio was 30 to 50%. 
MIF Production.--The  lymphocytes were incubated at 37°C in a humidified atmosphere of 
50-/0 CO2-95% air at a density of 1 X  107 or 5 X  106/ml except where otherwise noted. Usually 
no serum was included in the culture medium. However,  5% normal guinea pig serum was 786  PRODUCTION  OF MIF BY  B  CELLS 
added when CRL or NCRL were cultured separately since the viability of these cells and the 
resulting MIF production was higher in such medium. After 24 h  of incubation,  the super- 
natants were collected by two centrifugations at 3,000 rpm for 30 min, and then assayed for 
MIF activity without concentration. In those studies involving Sephadex gel filtration, the 
supernatants were concentrated by lyophilization (see below). Appropriate amounts of antigen 
or other test substance were added to reconstitute the control supernatants  which had been 
cultured in the absence of these substances.  In one set of experiments, endotoxin lipopoly- 
saccharide was used  to induce MIF. Two preparations  were used: Escherichia coli 055:B5 
lipopolysaccharide (Difco) and Serratia marcescens endotoxin  (Difco). These gave identical 
results, which are described below. 
Migration Inhibition Test.--This assay was performed as described previously (9, 10). The 
migration index  was  calculated  as  reported  there;  in addition,  the percent  inhibition was 
calculated as follows: 
% Inhibition  =  100 -- Migration Index. 
Macrophage Disappearance Reaction (MDR).--The  MDR was performed as described pre- 
viously (i1, 12). Briefly, nonimmnnized guinea pigs bearing 4-day glycogen-induced peritoneal 
exudates received intraperitoneal injections of lymphocytes with or without specific antigen. 
Peritoneal exudates were collected 5 h  later. Total cell counts of the suspensions  as well as 
differential counts on Giemsa-stained smears were performed. The percentage of macrophage 
loss  was calculated from the difference  between the average count for that cell type in the 
exudates of the control animals and the animals which had received antigen as well as donor 
cells. 
Sephadex Gel Filtration.--Supernatants obtained  from  the  culture  of normal  CRL with 
PPD were pooled. 50 ml of such material was concentrated to 3 ml by lyophi]ization. After 
removing insoluble debris by centrifugation at  3,000  rpm for  30 rain,  the preparation  was 
applied on a  2.5  >(  50 cm Sephadex G-100 column, which was equilibrated and eluted with 
PBS, pH 7.4.  The flow rate was adjusted  to 7 ml/h and 3 ml fractions were collected. Six 
pooled effluent fractions were collected and concentrated 10-fold as described previously (13, 
14). Control supernatants were treated exactly the same way. All of these fractions, in 4 ml of 
final volume, were dialyzed against  RPMI  1640 medium.  After sterilization by micropore 
filtration the various samples were assayed for MIF activity. 
RESULTS 
Production  of MIF by NCRL and CRL.--Groups  of  guinea  pigs  were  im- 
munized  with  egg  albumin,  DNP-EA  or  DNP-BSA  in  complete  Freund's 
adjuvant,  or  with  the  adjuvant  only.  CRL  and  NCRL  were  isolated  from 
regional  lymph  nodes  as  described.  In  this  set  of experiments,  the  CRL-rich 
suspensions  had purity of greater than 90 %  and the NCRL,  greater than 95 %. 
Each  population  of  cells was  cultured  in  the  presence  or  absence  of  its  own 
specific antigen  at  the  cell concentration  of 6  X  106/ml  for  24  h.  Viable  cell 
recoveries ranged from 57  to 65 %  (by Trypan  blue exclusion studies)  with no 
significant difference between control (antigen-free) and experimental  (antigen- 
containing)  cultures.  These figures were obtained for PPD  as well as the other 
test substances.  Similarly no significant differences in viability were found be- 
tween  CRL  and  NCRL  cultures.  These  viability figures  are  somewhat  lower 
than  those obtained  when using unfractionated  lymphocytes  (70-80 %); this is 
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such supernatants was tested using normal guinea pig peritoneal macrophages 
as indicator cells. The results are shown in Table I. Each of the antigens used 
could induce MIF production when added to cultures of NCRL from animals 
sensitized to that antigen. There was no significant difference with respect to 
EA, DNP-EA,  or DNP-BSA.  The CRL-rich suspensions could not make de- 
tectable MIF  when  cultured  with  the  appropriate  antigen  from this  group. 
Since all animals were immunized with antigens in complete Freund's adjuvant, 
all were sensitized to PPD. Interestingly, unlike the other antigens used, PPD 
could stimulate the CRL-rich population as well as the NCRL-rich population 
to produce MIF in culture. As mentioned above, the CRL-rich suspensions still 
contained approximately 10 % NCRL. It is possible that PPD is a sufficiently 
"good" antigen  to activate this small number of T  cells,  although  the other 
antigens were not.  This is not likely since the total amount of MIF activity 
recovered from the CRL suspensions was identical to that obtained from the 
NCRL suspensions. Nevertheless, this possibility was investigated by studying 
the dose-response characteristics of MIF production in this sytem. 
MIF  Production as a Function of NCRL Number.--In the method we  have 
used  to  separate  the  two  subpopulations  of  lymphocytes,  one  can  achieve 
greater purity of NCRL than CRL. Nevertheless, as stated above, each popula- 
tion retains some degree of contamination by the other. We therefore felt it of 
importance  to  compare  the  relative  abilities  of  different  concentrations  of 
NCRL to produce MIF under the culture conditions used, when PPD was used 
as the  stimulating  agent.  NCRL  and  CRL were separated from lymphocyte 
suspensions obtained from lymph nodes of guinea pigs immunized with com- 
plete Freund's adjuvant but no other antigen. As shown in Table II, suspen- 
sions of unfractionated lymphoeytes ("whole" suspensions) or of NCRL could 
release MIF into culture  at a  cell  concentration of 10  X  106/ml. At this cell 
concentration,  NCRL could produce MIF  at  a  level identical  to that  of the 
whole  suspension.  Reducing  the  concentration  of NCRL  reduced  the  MIF 
activity recoverable in  the  supernatants.  5  X  106  NCRL/ml  led  to  27.0% 
migration inhibition,  and when the dose was reduced further to  1  X  106/ml, 
TABLE I 
MIF Production by Sensitized NCRL and CRL 
Antigen* 
Lymphocyt  es:~ 
CRL  NCRL 
EA  --2.6 4-  7.2§  30.0  ±  2.4 
DNP-EA  --6.4  ±  4.2  28.1  ±  3.0 
DNP-BSA  7.6  ±  8.4  42.0  ±  5.6 
PPD  35.1  ±  5.9  30.9  -4- 8.4 
* Antigen in culture; 50 #g/ml. 
Cell concentration; 6 X  106/ml. 
§ % Inhibition  =  (1~ -- areaexp/areacont)  X  100. 788  PRODUCTION OF  MIF BY B  CELLS 
TABLE II 
MIF Production by Tuberculln-Sensitized NCRL and CRL as a Function of Cell Dose 
Lymphocyte suspension  Cell Conc.*  Inhibition 
% 
Whole  10  39.3  -4- 2.4 
NCRL  10  43.3  -4- 4.9 
5  27.0  -4- 2.6 
1  4.3  ±5.1 
CRL  5  37.6  :::k: 6.5 
* Cell conc. X  106/ml. These cells were cultured in the presence or absence of PPD (50 
#g/ml).  Control supernatants were reconstituted with PPD as described in the text. 
no detectable MIF activity was recoverable at all. The CRL-rich suspensions 
which were shown in Table I to give rise to supernatants with 37.6 % migration 
inhibition  contained less than 0.6  X  106 NCRL/ml.  Thus,  contamination  of 
that preparation by NCRL cannot be the explanation of its activity. 
Stimulation  of Nonimmune  CRL  by  PPD.--In  the  experiments  described 
above, CRL and NCRL from tuberculin-sensitized guinea pigs appear equally 
capable of producing MIF when stimulated by PPD in culture. Because of the 
discrepancy between the results with PPD  and those with the other antigens 
used, we explored the possibility that the activation of CRL by PPD might be 
"nonimmunologic" in nature. Accordingly, CRL and NCRL suspensions were 
prepared from lymphocytes obtained from lymph nodes on spleens of normal 
guinea pigs. These guinea pigs were not pretested with PPD, but, as indicated 
above,  a  random  sampling of othel  animals from the  same supplier showed 
them all to be negative to skin test with PPD.  Such normal CRL and NCRL 
were incubated with EA, DNP-EA, or PPD for 24 h. The culture supernatants 
were checked for MIF activity. Percent migration inhibition was calculated in 
comparison with  the migration  in  control  supernatants  which  were  cultured 
without  any  stimulating  substances  but  reconstituted  with  these  after  the 
incubation.  As expected, neither EA nor DNP-EA  could stimulate either the 
normal  CRL  or  NCRL  to  produce  MIF.  However,  tuberculin  PPD  could 
stimulate  normal  CRL  from  either  lymph  node  or  spleen,  but  not  normal 
NCRL  from  these  sources,  to  produce  MIF.  50  #g/ml  of PPD  resulted  in 
preparations with  approximately 30 % migration inhibition.  These results are 
summarized in Table III. Not shown are data for 10 ~g/ml PPD  (21% inhibi- 
tion) and 1 #g/ml PPD  (14% inhibition). This latter figure does not represent 
significant activity by the usual  criteria for MIF studies,  but is significantly 
higher than the values obtained with NCRL at any dose of PPD (<6%). 
Characterization  of CRL-Derived  MIF.--The  macrophage migration  inhibi- 
tory substance  obtained  from the  stimulation  of nonimmune  CRL  by PPD 
need not be identical to the "classic" MIF obtained by the specific stimulation 
of sensitized  T  cells.  In  order  to characterize this material,  column  chroma- T.  YOSHIDA, H.  SONOZAKI, AND  S.  COHEN  789 
tography  studies,  on  Sephadex  G-100,  were  performed  on  the  active  super- 
natants from the PPD-stimulated nonimmune  CRL.  Six approximately equal 
volumes of eluate fractions were pooled and tested for MIF activity. Inhibitory 
activity of each  fraction was  compared with  that  of corresponding fractions 
obtained by the gel filtration of control supernatants. MIF activity was mainly 
found in Fraction III whose molecular weight corresponded approximately to 
that of ovalbumin, and also, in small amount,  in Fraction V  whose molecular 
weight corresponds approximately to that of cytochrome C. These results are 
shown in Fig. 1. The elution pattern of this CRL-derived MIF is quite similar 
to  that  obtained by column  chromatography  on  Sephadex  of culture  super- 
natants obtained from  antigen-specific stimulation of sensitized lymphocytes, 
as reported by us and others (13-15). 
TABLE III 
MIF Production by PPD Stimulation of Lymphocytes Obtained from Normal Animals 
Lymphocyte  source  Antigen*  CRL:~  NCRLkt 
Lymph node  EA  4.6  4-  8.8§  1.0  ~  2.9 
PPD  31.2  -4- 5.3  5.8  -4- 6.3 
Spleen  EA  9.2  :t=  5.1  9.0  +  3.8 
DNPEA  8.8  -4- 4.0  9.3  :t: 4.0 
PPD  31.8  :t- 4.0  1.5  4-  2.5 
* Antigen concentration: 50/zg/ml. 
Cell concentration: 10 X  10S/ml. 
§ % Inhibition. 
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FIG. 1.  Sephadex G-100 gel filtration of supernatant obtained from normal CRL cultured 
with PPD. Arrows indicate the positions where marker proteins eluate; guinea pig albumin 
(mol wt 67,000) ovalbumin (tool wt 45,000) and cytochrome  C (mol wt 12,400). Fractions of 
3 ml/tube were collected and pooled into six approximately equal volume  (30 ml) fractions. 
Each fraction after 10-fold concentration was tested for MIF activity. 790  PRODUCTION  OF  MLF  BY  B  CELLS 
In addition, other physicochemical characteristics of this MIF preparation 
were studied. The material was not cytotoxic for macrophages on the basis of 
Trypan blue exclusion studies. It did not lose its MIF activity by heating at 
56°C for 30 rain, but lost activity by heating at 80°C for 1 h. Trypsin digestion 
of the material at the enzymatic concentration of 5 mg/ml resulted in a total 
loss of MIF activity. These characteristics were also identical to that of classical 
MIF. 
Stimulation  of  CRL  by  Endotoxin  Lipopolysaccharide.--Since  PPD  could 
stimulate CRL (B cells) to produce MIF, it was of interest to determine whether 
or not endotoxin lipopolysaccharide, which is a known B  cell mitogen in the 
guinea pig (16), could do so as well. Accordingly, 20 #g/ml of endotoxin lipo- 
polysaccharide (Difco) was added to the cultures of normal  CRL or NCRL. 
It was found that supernatants obtained from CRL cultured in the presence of 
this material showed macrophage migration inhibitory activity, although  the 
activity recovered was  somewhat  weaker than  that  obtained by stimulation 
with 20 #g/ml of PPD, averaging 24 % inhibition. 
Macrophage  Disappearance  Reaction  (MDR).--As  stated  previously,  the 
MDR elicited by pure soluble protein antigen has been found to be mediated 
by T  cells.  Because of the observations reported here,  those studies were re- 
peated using PPD as eliciting agent. In this experiment, CRL and NCRL were 
separated  from lymph nodes of guinea pigs immunized with  egg albumin  in 
complete Freund's adjuvant. The results are shown in Table IV. 2 X  108 cells 
of NCRL and 40 #g of egg albumin when injected into nonimmunized guinea 
pigs bearing 4-day glycogen-induced peritoneal exudates could induce the MDR 
with a  77.5% loss of peritoneal macrophages,  but  the same amount of CRL 
and antigen was entirely negative, confirming the previously reported results 
(3). However, PPD  could stimulate both CRL  and NCRL,  causing 50.5  and 
69.3 % loss of macrophages, respectively. These figures are the average of three 
independent experiments each performed in triplicate. Thus, the in vitro results 
reported above are confirmable in an in vivo system. The ability to transfer 
the MDR with nonimmune lymphocytes and PPD  was not examined in this 
set of studies. 
TABLE IV 
Ability of Sensitized NCRL and CRL to Elicit a Macrophage Disappearance Reaction 
Lymphocytes  Antigen*  Macrophage loss 
% 
NCRL~:  EA  77.5 
PPD  69.3 
CRL§  EA  3.8 
PPD  50.5 
* Cell dose, 2 X  106; purity 95%. 
:~ Cell dose, 2 )< 10s; purity 88%. 
§ Antigen dose 40 #g. T.  YOSHIDA,  H.  SONOZAKI,  AND  S.  COHEN  791 
DISCUSSION 
In the present study, we have separated guinea pig lymphocytes into two 
populations on the basis of the presence or absence of a receptor for the third 
component of complement on their cell surfaces. It has been well documented 
that the cells which lack this receptor (NCRL) correspond to T  cells,  and that 
the cells which possess this receptor (CRL) correspond to B cells (4-6). Making 
use of these associations, we have shown that several antigens are capable of 
stimulating relatively pure populations of T, but not B cells, from appropriately 
immunized animals,  to produce and/or release MIF into culture supernatant 
fluids in vitro. This is analogous to the results of our previous studies on the 
macrophage disappearance reaction (S) which represents an in vivo analog of 
the migration inhibition reaction. T  cells,  but not B  cells were shown to be 
capable of mediating the macrophage disappearance reaction, when transferred 
with specific antigen into nonimmune hosts (S). This reaction could be accom- 
plished even when the cells were enclosed in micropore chambers. Those experi- 
ments, and the studies reported here, represent the first direct documentation 
that lymphokines are produced by T  cells. These results are not surprising in 
the light of the overwhelming evidence that the various manifestations of cell- 
mediated immunity are dependent upon T  cell function (17,  18). What is sur- 
prising is that PPD,  of the several antigens  tested, was capable of inducing 
similar activities in a population composed predominantly of B  cells.  B  cells 
activated by PPD  could mediate both the migration inhibition reaction and 
the macrophage disappearance reaction. The substance responsible for migra- 
tion inhibition had physicochemical properties consistent with those of "classic" 
MIF and may well be identical to it. Quantitative considerations, as presented 
in the previous section, argued against the possibility that the contaminant T 
cells in our B cell-rich suspensions were the cause of this activity. 
A finding of major importance in this study was that PPD could also stim- 
ulate B  cell-rich suspensions obtained from nonimmunized donors to produce 
MIF.  Unlike the  situation  when  sensitized  cells  were used,  PPD  could not 
stimulate the T  cells from the nonimmunized donors. This fact lends further 
support to  our  contention  that  this  group  of animals  was  not  presensitized 
to products of the tubercle bacillus. Moreover, it shows that the ability of the 
B  cell suspensions  to produce MIF  could not be due to the presence of the 
small numbers of T  cells in  those B  cell  suspensions.  Since similar levels of 
activity were  obtained  when  PPD  was  added  to  the  CRL  from  sensitized 
donors,  these findings reinforce our conclusion, based upon  the  quantitative 
considerations above, that the results were not due to contaminant T  cells in 
that situation as well. The possibility that the B cells are interacting with, and 
enhancing the ability of a small number of critical T cells in this system to make 
MIF is unlikely, not only because it would represent a lymphocyte-lymphocyte 
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ment of B cell function by T  cells (helper function), but also because it would 
represent the consequence of such inverse interaction in a nonimmune as well 
as immune system. In any case, even if this alternate possibility should turn 
out to be correct, the observations reported here point to a previously unre- 
ported capability of B cells. 
It is of interest that the phenomenon reported here has never been observed 
in controls for the usual indirect migration inhibition reaction performed with 
PPD  as  antigen.  In  the  typical  experimental  setting,  the  control  involves 
culturing an aliquot  of sensitized lymphocytes without antigen,  and then re- 
constituting the supernatant fluids with antigen at the end of the incubation 
period. This supernatant, containing PPD, but no MIF, is added to peritoneal 
exudates from normal animals. In the light of the observations reported here, 
the PPD might be expected to activate the B cells in that exudate. The failure 
to  detect such  a  reaction  is  most  likely related  to  our previously reported 
observations on the very low content of B cells in peritoneal exudates used in 
migration  inhibition  studies.  In  those  preparations,  more  than  95 %  of  the 
lymphocytes are T  cells (3). Parenthetically, this fact also provides a partial 
explanation  for  the  relatively greater ability of peritoneal  exudate ceils,  as 
compared to lymph node suspensions, to mediate various reactions of cellular 
immunity (19-21). 
It is  well-known  that various mitogens can stimulate normal lymphocytes 
from nonimmune animals to produce MIF-like substances (22, 23). In at least 
one such study, it has been shown that the material produced has character- 
istics  which  are identical  to MIF produced by antigen-stimulated  sensitized 
lymphocytes (22). Recently, Sultzer and Nilsson have reported that PPD  is 
also mitogenic, but that unlike most of the known mitogens, it appears to act 
selectively on B cells of the mouse (24). To confirm this point, we have studied 
thymidine incorporation in normal guinea pig CRL  and NCRL during PPD 
stimulation. PPD  (50 #g/ml) produces an approximately threefold increase in 
thymidine incorporation in  CRL  but has no effect on NCRL.  These results, 
though significant, are slightly less than those reported by Sultzer and Nilsson 
who obtained incorporation ratios of 3.8  to 4.5  using  cells from nude  mice. 
Since PPD  could activate lymphocytes from nonimmune,  as well  as immune 
donors in these studies, it appears as if its MIF-inducing ability might well be 
related to its mitogenic ability. It is, of course, possible that the active substance 
in our studies and in the work of Sultzer and Nilsson was not PPD itself but 
some contaminant within the preparations used. The fact that we could obtain 
MIF  production  by  incubating  B  cells  with  endotoxin  lipopolysaccharide, 
another mitogenic substance which affects B cells (16), lends credence to this 
possibility, and in addition, provides support for the notion that MIF produc- 
tion by nonimmunized B  cells could be related  to  a  mitogenic effect of the 
stinmlating substances. 
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of these observations. First,  our data provide no evidence that  B  cells from 
immune  animals  are more effective in producing MIF  than those from non- 
immune  animals.  Thus,  the  induction  of MIF  by stimulation  of  sensitized 
lymphocytes with  specific antigen probably represents  a  purely T  cell phe- 
nomenon. This is analogous to the situation in which the in vitro stimulation 
of DNA synthesis in lymphoid cells from immunized animals by specific antigen 
was studied. Here, removal of T  cells by lysis with an appropriate antiserum 
largely abolished the capacity of the cell population to manifest this response 
(25),  whereas  enrichment of T  cells by glass  bead  column chromatography 
enhanced the response (26). Thus, in  two distinct in vitro systems, both of 
which  correlate  with  cell-mediated  immunity,  specific  antigen  activates  T 
rather than B  cells.  The situation with respect to nonantigenic activation is 
quite different. Nonspecific agents may function as B  cell mitogens, inducing 
blast transformation and DNA synthesis. These include not only the substances 
studied in the present experiments, but also agents previously considered to be 
only T  cell mitogens,  such  as  pokeweed mitogen,  phytohemagglutinin,  and 
concanavalin A  (16). Similarly, as we have shown, nonimmunologic activation 
of a B cell population can lead to the appearance of MIF activity. This raises 
the possibility that various other lymphokines, in addition to MIF,  could be 
generated by similar mechanisms. 
In vivo, antigen must somehow lead to a wave of proliferative activity in an 
appropriate  subpopulation  of the  B  cell  series,  in  order  to  account for the 
observed kinetics of antibody formation in both the primary and secondary 
response. As stated above, antigen-induced activation of B cells for proliferation 
has not been observed in vitro. Since there is abundant evidence that lympho- 
cytes which play a role in cell-mediated immunity may produce lymphokines 
with mitogenic activity (reviewed in 27), it is possible that at least some of these 
agents might act selectively on B cells. In other words, T  cells might function 
in vivo in a manner similar to that of endotoxin lipopolysaccharide or PPD 
in vitro. In support of this possibility, it has been shown that endotoxin lipo- 
polysaccharide could alter thymic-deficient mice so that they could respond to 
thymic-dependent antigens (28), and that endotoxin could induce an immune 
response in mice to a hapten coupled to a nonimmunogenic carrier (29). These 
experiments are difficult to interpret since unlike the situation in guinea pigs 
endotoxin lipopolysaccharide stimulates T  cells as well as B cells in the mouse 
(16). Nevertheless, an endogenous mitogen for B cells might provide one mech- 
anism by which the "helper" function of T  cells expresses itself. It has been 
shown that "helper" functions may be mediated by soluble factors released by 
T  cells (27,  30). Although a  lymphokine specifically mitogenic for B  cells has 
not  yet been  described,  it  is  of interest  that  humoral  factors produced by 
thymocytes may potentiate the ability of concanavalin A  to activate B  cell~ 
(31).  Moreover,  activated  lymphocyte  cultures  have  a  small  but  definite 
mitogenic effect on spleen cells from nude mice, which lack T  cells (32). This 794  PRODUCTION  OF  MIF  BY  B  CELLS 
possibility is currently under investigation in our laboratory. In any case, once 
B cell activation occurs, production of lymphokines by these cells, as well as T 
cells, would provide for further amplification of the immune response. 
As a final comment, it has been shown that MIF, or substances with similar 
biologic and physicochemical properties may be found in  certain replicating 
cultures  of nonlymphoid cells  (33,  34).  Also,  we  have  recently shown  that 
migration  inhibition  activity  (35,  36),  as  well  as  certain  other lymphokine 
activities such  as macrophage and lymphocyte chemotaxis (37), may appear 
after the in vitro or in vivo infection of nonlymphoid, as well as lymphoid cells 
by mumps or Newcastle disease virus. These results, taken in conjunction with 
those reported here, suggest that lymphokine production, rather than merely 
representing an effector mechanism for cell-mediated immunity, represents a 
general biologic phenomenon which may play a role in various aspects of host 
defense. In this view, the lymphocyte has acquired some specialized means for 
triggering this production, not available to other cells.  B  cells may do so by 
mitogenic activation, and T  cells by either mitogenic or antigenic activation. 
SIYMMARY 
Stimulation of sensitized lymphocytes by specific antigen in vitro leads to the 
production of migration inhibition factor (MIF). In the case of the pure soluble 
protein, or hapten-protein antigens used in the present studies, this MIF pro- 
duction was  a property of the T  lymphocytes in the cell suspensions.  When 
PPD was used, B cells, as well as T cells, produced MIF. Similarly, PPD could 
stimulate B cells to mediate the macrophage disappearance reaction, a reaction 
which is known to be a T cell-dependent in vivo manifestation of cell-mediated 
immunity. Suspensions of lymphocytes from nonimmune donors could also be 
stimulated by PPD; in this case, B cells,  but not T  cells, produced MIF. The 
factors produced by the two lymphocyte subpopulations appeared to be similar, 
if not identical, on the basis of physico-chemical criteria. It is suggested that 
PPD  stimulates  B  cells for MIF production because of its  role as  a  B  cell 
mitogen. The ability of endotoxin lipopolysaccharide, another B  cell mitogen, 
to also induce MIF production by B  cells supports this contention. Thus, al- 
though activation of lymphocytes for MIF production by specific antigen is a 
property of T cells, B cells as well as T cells may be.so activated by agents which 
act nonspecifically. This may prove to have implications  for in  vivo events 
involved in immunization. In addition, these observations lend further support 
to the concept that lymphokine production represents a  general biologic phe- 
nomenon in addition to playing a role in the effector mechanisms for reactions 
of cell-mediated immunity. 
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